Publication | Open Access

A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties

Human GrowthTargeted InhibitionGlycobiologyImmunologyAntibody ScreeningImmunochemistryAntibody EngineeringImmunoglobulin EImmunotherapyMedicineCell BiologyDrug Discovery